Columnist Marisa Zeppieri faces a dilemma when she's asked "How are you?" One choice is to answer truly, another to answer ...
The U.S. Food and Drug Administration (FDA) has agreed to review an application by Roche seeking approval of obinutuzumab for the treatment of lupus nephritis, a lupus complication marked by kidney ...
It’s so easy to jump on the woe-is-me, this-isn’t-fair, what-did-I-do-to-deserve-this bandwagon and shout, kick, and scream at the awful “bad luck” and horrible timing of chronic, incurable sickness.
It’s so easy to jump on the woe-is-me, this-isn’t-fair, what-did-I-do-to-deserve-this bandwagon and shout, kick, and scream at the awful “bad luck” and horrible timing of chronic, incurable sickness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback